Pharmaceutical group

Aiping

5 medicines2 countries

A group of 2 companies with 5 medicines in 2 countries.

Its medicines

Group structure

2 companies in 2 countries

Canada1

Aiping Pharmaceutical IncAuthorisation holder · 1 medicine

United States1

Aiping Pharm IncAuthorisation holder · 4 medicines

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

5 medicines

Medicine	Substance	Country	Status	Authorised
CIPROFLOXACIN100mg \| 250mg · Tablet	Ciprofloxacin	United States	Marketed	2004
GLIPIZIDE10mg \| 15mg \| 2.5mg \| 5mg · Tablet	Glipizide	United States	Marketed	1994
PREVALITE4gm resin/packet \| 4gm resin/scoopful · Powder	Colestyramine	United States	Marketed	1996
SORINE120mg \| 160mg \| 240mg \| 80mg · Tablet	Sotalol	United States	Marketed	2001
DOCUSATE SODIUM CAPSULES, USP 100MG100 mg · Capsule	Docusate	Canada	Cancelled

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Pharmaceutical group

Aiping

5 medicines2 countries

A group of 2 companies with 5 medicines in 2 countries.

Its medicines

Group structure

2 companies in 2 countries

Canada1

Aiping Pharmaceutical IncAuthorisation holder · 1 medicine

United States1

Aiping Pharm IncAuthorisation holder · 4 medicines

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

5 medicines

Medicine	Substance	Country	Status	Authorised
CIPROFLOXACIN100mg \| 250mg · Tablet	Ciprofloxacin	United States	Marketed	2004
GLIPIZIDE10mg \| 15mg \| 2.5mg \| 5mg · Tablet	Glipizide	United States	Marketed	1994
PREVALITE4gm resin/packet \| 4gm resin/scoopful · Powder	Colestyramine	United States	Marketed	1996
SORINE120mg \| 160mg \| 240mg \| 80mg · Tablet	Sotalol	United States	Marketed	2001
DOCUSATE SODIUM CAPSULES, USP 100MG100 mg · Capsule	Docusate	Canada	Cancelled

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
United States	4	4	0	Companies All medicines
Canada	1	0	1	Companies All medicines

Therapeutic areas

The ATC groups most of its medicines belong to, largest first.

Drugs for constipationAlimentary tract and metabolism · ATC A06A

Top substances

The active substances in most of its medicines.

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Report an error or request removalCorrections from the company itself are welcome.

At a glance

Type: Pharmaceutical group
Companies: 2
Medicines: 5
Countries: 2

Other big groups

Well-known pharmaceutical groups, each with all its companies.

Show all

Group structure

🇨🇦Canada1

🇺🇸United States1

Medicines

Know your medicines, with the sources.

Group structure

🇨🇦Canada1

🇺🇸United States1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Sources and licences

At a glance

Canada1

United States1

Canada1

United States1